{"id":"NCT02621892","sponsor":"Ardelyx","briefTitle":"A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C","officialTitle":"A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-10","primaryCompletion":"2017-03","completion":"2017-04","firstPosted":"2015-12-04","resultsPosted":"2020-04-21","lastUpdate":"2020-04-21"},"enrollment":606,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Constipation Predominant Irritable Bowel Syndrome"],"interventions":[{"type":"DRUG","name":"Tenapanor","otherNames":["RDX5791","AZD1722"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"50mg BID","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This phase 3, 12-week, randomized, double-blind, placebo-controlled, multi-center study will evaluate the safety and efficacy of tenapanor in subjects with constipation-predominant irritable bowel syndrome (IBS-C) as defined by the ROME III criteria and who have active disease as determined after a two-week screening period. Subjects who qualify and are randomized into the study will either receive 50mg BID of tenapanor or placebo BID for 12 week treatment period and then undergo a 4 week placebo controlled randomized withdrawal.","primaryOutcome":{"measure":"6 of 12 Week Overall Responder Rate","timeFrame":"12 weeks","effectByArm":[{"arm":"50mg BID","deltaMin":83,"sd":null},{"arm":"Placebo","deltaMin":56,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.02"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":111,"countries":["United States"]},"refs":{"pmids":["33337659","31934897"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":307},"commonTop":["Diarrhea"]}}